Search

Your search keyword '"Porcher, Raphael"' showing total 821 results

Search Constraints

Start Over You searched for: Author "Porcher, Raphael" Remove constraint Author: "Porcher, Raphael"
821 results on '"Porcher, Raphael"'

Search Results

1. Estimating Complier Average Causal Effects with Mixtures of Experts

2. Do machine learning methods lead to similar individualized treatment rules? A comparison study on real data

3. A Comprehensive Framework for the Evaluation of Individual Treatment Rules From Observational Data

4. How to improve the quality of comparisons using external control cohorts in single-arm clinical trials?

5. Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study

7. Epidemic Models for COVID-19 during the First Wave from February to May 2020: a Methodological Review

9. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

11. Wasserstein Random Forests and Applications in Heterogeneous Treatment Effects

12. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases

15. A novel approach for identifying and addressing case-mix heterogeneity in individual participant data meta-analysis

18. Platform trials

19. Les essais plateformes

22. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

23. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

24. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region

25. A Novel Approach for Identifying and Addressing Case-Mix Heterogeneity in Individual Participant Data Meta-Analysis

26. Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups

28. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

29. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

30. More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients

31. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

32. Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study

33. Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial

38. Host-pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study

40. Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu’s Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011

41. Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

43. More rapid blood interferon a2 decline in fatal versus surviving COVID-19 patients C.

46. Supplementary Data from Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients

47. Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: a French nationwide study from the Epithor cohort database

49. Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

50. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials

Catalog

Books, media, physical & digital resources